Bioventus Stock Technical Analysis
| BVS Stock | USD 7.89 0.13 1.62% |
As of the 27th of January, Bioventus shows the Downside Deviation of 2.36, mean deviation of 2.17, and Risk Adjusted Performance of 0.0539. Bioventus technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Bioventus coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if Bioventus is priced correctly, providing market reflects its regular price of 7.89 per share. Given that Bioventus has jensen alpha of 0.1234, we suggest you to validate Bioventus's prevailing market performance to make sure the company can sustain itself at a future point.
Bioventus Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Bioventus, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BioventusBioventus | Build AI portfolio with Bioventus Stock |
Bioventus Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 15.0 | Strong Buy | 3 | Odds |
Most Bioventus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Bioventus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Bioventus, talking to its executives and customers, or listening to Bioventus conference calls.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioventus. If investors know Bioventus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioventus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.16 | Revenue Per Share | Quarterly Revenue Growth (0) | Return On Assets | Return On Equity |
The market value of Bioventus is measured differently than its book value, which is the value of Bioventus that is recorded on the company's balance sheet. Investors also form their own opinion of Bioventus' value that differs from its market value or its book value, called intrinsic value, which is Bioventus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioventus' market value can be influenced by many factors that don't directly affect Bioventus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioventus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioventus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioventus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bioventus 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bioventus' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bioventus.
| 10/29/2025 |
| 01/27/2026 |
If you would invest 0.00 in Bioventus on October 29, 2025 and sell it all today you would earn a total of 0.00 from holding Bioventus or generate 0.0% return on investment in Bioventus over 90 days. Bioventus is related to or competes with Treace Medical, Orthopediatrics Corp, Standard Biotools, CeriBell, Butterfly Network, Varex Imaging, and Cytek Biosciences. Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and e... More
Bioventus Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bioventus' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bioventus upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.36 | |||
| Information Ratio | 0.0383 | |||
| Maximum Drawdown | 22.05 | |||
| Value At Risk | (3.49) | |||
| Potential Upside | 5.12 |
Bioventus Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bioventus' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bioventus' standard deviation. In reality, there are many statistical measures that can use Bioventus historical prices to predict the future Bioventus' volatility.| Risk Adjusted Performance | 0.0539 | |||
| Jensen Alpha | 0.1234 | |||
| Total Risk Alpha | (0.12) | |||
| Sortino Ratio | 0.0534 | |||
| Treynor Ratio | 0.1899 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bioventus' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bioventus January 27, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0539 | |||
| Market Risk Adjusted Performance | 0.1999 | |||
| Mean Deviation | 2.17 | |||
| Semi Deviation | 2.13 | |||
| Downside Deviation | 2.36 | |||
| Coefficient Of Variation | 1589.75 | |||
| Standard Deviation | 3.29 | |||
| Variance | 10.83 | |||
| Information Ratio | 0.0383 | |||
| Jensen Alpha | 0.1234 | |||
| Total Risk Alpha | (0.12) | |||
| Sortino Ratio | 0.0534 | |||
| Treynor Ratio | 0.1899 | |||
| Maximum Drawdown | 22.05 | |||
| Value At Risk | (3.49) | |||
| Potential Upside | 5.12 | |||
| Downside Variance | 5.58 | |||
| Semi Variance | 4.54 | |||
| Expected Short fall | (2.76) | |||
| Skewness | 1.88 | |||
| Kurtosis | 6.75 |
Bioventus Backtested Returns
Bioventus appears to be slightly risky, given 3 months investment horizon. Bioventus secures Sharpe Ratio (or Efficiency) of 0.0918, which signifies that the company had a 0.0918 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Bioventus, which you can use to evaluate the volatility of the firm. Please makes use of Bioventus' Downside Deviation of 2.36, mean deviation of 2.17, and Risk Adjusted Performance of 0.0539 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Bioventus holds a performance score of 7. The firm shows a Beta (market volatility) of 1.04, which signifies a somewhat significant risk relative to the market. Bioventus returns are very sensitive to returns on the market. As the market goes up or down, Bioventus is expected to follow. Please check Bioventus' semi variance, and the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Bioventus' price patterns will revert.
Auto-correlation | -0.05 |
Very weak reverse predictability
Bioventus has very weak reverse predictability. Overlapping area represents the amount of predictability between Bioventus time series from 29th of October 2025 to 13th of December 2025 and 13th of December 2025 to 27th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bioventus price movement. The serial correlation of -0.05 indicates that only as little as 5.0% of current Bioventus price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.05 | |
| Spearman Rank Test | 0.2 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Bioventus technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Bioventus Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Bioventus volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Bioventus Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Bioventus on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Bioventus based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Bioventus price pattern first instead of the macroeconomic environment surrounding Bioventus. By analyzing Bioventus's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Bioventus's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Bioventus specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 5.01E-4 | 4.76E-4 | Price To Sales Ratio | 1.38 | 1.31 |
Bioventus January 27, 2026 Technical Indicators
Most technical analysis of Bioventus help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Bioventus from various momentum indicators to cycle indicators. When you analyze Bioventus charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0539 | |||
| Market Risk Adjusted Performance | 0.1999 | |||
| Mean Deviation | 2.17 | |||
| Semi Deviation | 2.13 | |||
| Downside Deviation | 2.36 | |||
| Coefficient Of Variation | 1589.75 | |||
| Standard Deviation | 3.29 | |||
| Variance | 10.83 | |||
| Information Ratio | 0.0383 | |||
| Jensen Alpha | 0.1234 | |||
| Total Risk Alpha | (0.12) | |||
| Sortino Ratio | 0.0534 | |||
| Treynor Ratio | 0.1899 | |||
| Maximum Drawdown | 22.05 | |||
| Value At Risk | (3.49) | |||
| Potential Upside | 5.12 | |||
| Downside Variance | 5.58 | |||
| Semi Variance | 4.54 | |||
| Expected Short fall | (2.76) | |||
| Skewness | 1.88 | |||
| Kurtosis | 6.75 |
Bioventus January 27, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Bioventus stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 5,241 | ||
| Daily Balance Of Power | (0.54) | ||
| Rate Of Daily Change | 0.98 | ||
| Day Median Price | 8.00 | ||
| Day Typical Price | 7.96 | ||
| Price Action Indicator | (0.17) |
Additional Tools for Bioventus Stock Analysis
When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.